Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
for crawled date : 2020 - 12 - 03 save search
FTAI Aviation Announces Agreement with AAR for Serviceable Engine Products, a Partnership to Provide CFM56 Engine Material to Global Aviation Aftermarket
Published: 2020-12-03 (Crawled : 22:01) - globenewswire.com
FTAI | $71.74 1.01% 640K
|
Finance
|
| O: 2.29%
H: 5.62%
C: 5.3%
AIR S | $60.96 0.5% 53K
|
Electronic Technology
|
| O: 2.74%
H: 2.46%
C: 1.91%
partnership
Frequency Electronics, Inc. Announces Award of a Contract for Precision Voltage Controlled Quartz Crystal Oscillators (VCXO)
Published: 2020-12-03 (Crawled : 22:01) - globenewswire.com
FEIM | $9.76 -0.41% 18K
|
Electronic Technology
|
| O: 2.35%
H: 0.72%
C: 0.43%
contract electronics awards
AAR announces agreement with FTAI for Serviceable Engine Products, a partnership to provide CFM56 engine material to the global aviation aftermarket
Published: 2020-12-03 (Crawled : 22:01) - globenewswire.com
FTAI | $71.74 1.01% 640K
|
Finance
|
| O: 2.29%
H: 5.62%
C: 5.3%
AIR S | $60.96 0.5% 53K
|
Electronic Technology
|
| O: 2.74%
H: 2.46%
C: 1.91%
partnership
Credit Acceptance Named to the Best Workplaces for Parents™ List
Published: 2020-12-03 (Crawled : 21:04) - globenewswire.com
CACC | $538.165 -1.69% 29K
|
Finance
|
| O: 0.56%
H: 0.83%
C: -0.33%
FutureFuel Corp. Declares Quarterly Dividend Program for 2021
Published: 2020-12-03 (Crawled : 21:02) - globenewswire.com
FF | $5.775 -2.12% 280K
|
Process Industries
|
| O: 0.84%
H: 1.0%
C: 0.17%
program
Greenwich LifeSciences Announces New Manufacturing Agreement for its Planned Phase III Clinical Trial and Enters into Lease for Office and Lab Space
Published: 2020-12-03 (Crawled : 20:00) - biospace.com/
GLSI | $14.43 1.19% 12K
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: -0.85%
space spac trial
Completion of Balstilimab BLA Filing Extended To 1H2021Agenus to fulfill FDA feedback for six-month follow-up on late responders
Published: 2020-12-03 (Crawled : 19:00) - biospace.com/
AGEN 4 | $6.875 5.77% 680K
|
Health Technology
|
| O: -1.1%
H: 2.51%
C: -5.57%
fda
CMS Confirms Continued Separate Payment for Omeros’ FDA-Approved OMIDRIA® in Ambulatory Surgery Centers
Published: 2020-12-03 (Crawled : 19:00) - biospace.com/
OMER | $3.445 1.92% 200K
|
Health Technology
|
| O: 15.88%
H: 2.75%
C: -1.0%
fda approval fda approval
InMed Licenses MiDROPS Delivery Technology from EyeCRO for the Delivery of Therapeutic Cannabinoids
Published: 2020-12-03 (Crawled : 19:00) - biospace.com/
INM 4 | $0.303 -4.93% 750K
|
Health Technology
|
| O: -0.55%
H: 9.53%
C: -3.16%
license eye liver drop
Moleculin To Present Antitumor Activity of Annamycin in Combination with Ara-C in AML at American Society for Hematology Annual Conference
Published: 2020-12-03 (Crawled : 17:00) - biospace.com/
MBRX | $4.355 -2.35% 9.7K
|
Health Technology
|
| O: 3.01%
H: 0.0%
C: -3.07%
aml
Eyenovia Announces FDA Acceptance of IND for MicroLine for Presbyopia, Clearing Path to Initiate Phase 3 VISION Trial by Year End
Published: 2020-12-03 (Crawled : 17:00) - biospace.com/
EYEN | $0.5492 -0.09% 690K
|
Health Technology
|
| O: 3.66%
H: 1.63%
C: -1.9%
fda eye phase 3 trial fda acceptance presbyopia
Alnylam Completes Enrollment in ILLUMINATE-C Phase 3 Study of Lumasiran, an RNAi Therapeutic, for the Treatment of Advanced Primary Hyperoxaluria Type 1
Published: 2020-12-03 (Crawled : 16:00) - biospace.com/
ALNY | $147.495 -0.14% 110K
|
Health Technology
|
| O: 0.41%
H: 2.21%
C: 0.9%
phase 3 treatment enroll
Iterum Therapeutics Announces Topline Results for a Phase 3 Clinical Trial of Oral and IV Sulopenem in Complicated Urinary Tract Infection
Published: 2020-06-01 (Crawled : 15:41) - globenewswire.com
ITRM | $1.465 -6.69% 150K
|
Health Technology
|
| O: -62.49%
H: 38.7%
C: 7.66%
results phase 3 trial sulopenem topline injection infections
Iterum Therapeutics Announces Topline Results from its Phase 3 Clinical Trial of Oral Sulopenem for the Treatment of Uncomplicated Urinary Tract Infections
Published: 2020-06-29 (Crawled : 15:40) - globenewswire.com
ITRM | $1.465 -6.69% 150K
|
Health Technology
|
| O: -4.58%
H: 0.68%
C: -2.74%
results phase 3 trial sulopenem treatment topline injection infections
Iterum Therapeutics Informs Shareholders of Record Date for Planned Rights Offering
Published: 2020-07-13 (Crawled : 15:40) - globenewswire.com
ITRM | $1.465 -6.69% 150K
|
Health Technology
|
| O: -11.5%
H: 3.0%
C: 0.0%
offering
Iterum Therapeutics Announces Positive Pre-NDA Meeting with FDA for Sulopenem for Treatment of Uncomplicated Urinary Tract Infections
Published: 2020-09-30 (Crawled : 15:40) - globenewswire.com
ITRM | $1.465 -6.69% 150K
|
Health Technology
|
| O: 155.13%
H: 48.78%
C: -35.98%
positive fda sulopenem treatment injection infections
Iterum Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem
Published: 2020-11-30 (Crawled : 15:40) - globenewswire.com
ITRM | $1.465 -6.69% 150K
|
Health Technology
|
| O: -0.59%
H: 1.57%
C: -3.47%
food drug sulopenem new drug application
Abeona Therapeutics Announces Upcoming Data Presentations at the Society for Pediatric Dermatology 45th Annual Meeting
Published: 2020-06-18 (Crawled : 15:27) - globenewswire.com
ABEO | $7.85 2.75% 120K
|
Health Technology
|
| O: 0.0%
H: 7.92%
C: 2.97%
Abeona Therapeutics Announces Two Presentations Related to Its RDEB Clinical Program at the Society for Pediatric Dermatology 45th Annual Meeting
Published: 2020-07-10 (Crawled : 15:27) - globenewswire.com
ABEO | $7.85 2.75% 120K
|
Health Technology
|
| O: -3.58%
H: 1.24%
C: -6.81%
Abeona Therapeutics and Taysha Gene Therapies Enter into Licensing and Inventory Purchase Agreements for ABO-202, a Clinical Stage, Novel, One-time Gene Therapy for CLN1 Disease
Published: 2020-08-17 (Crawled : 15:27) - globenewswire.com
ABEO | $7.85 2.75% 120K
|
Health Technology
|
| O: 8.73%
H: 0.0%
C: -3.68%
license therapy gene therapy disease gene therapies aβos
Gainers vs Losers
| 55% | 45% |
Top 10 Gainers
WISA 4 | $5.33 204.57% 190M
|
Electronic Technology
TPET | $0.5189 124.54% 38M
|
n/a
SXTC | $1.78 52.14% 33M
|
Health Technology
JAGX | $0.1771 49.07% 540M
|
Health Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
MCBC | $13.74 38.37% 1.6M
|
Finance
FNCH | $2.98 32.74% 400K
|
Professional, Scientific, and T...
PALI | $5.51 32.45% 28M
|
Manufacturing
VERO | $0.804 31.8% 110K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.